Literature DB >> 20304153

Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.

R S Castro1, D Deisanti, T Seva-Pereira, J R S Almeida, A Yamanaka, I F S F Boin, E C Soares.   

Abstract

INTRODUCTION: To examine whether the official adoption of Model for End-Stage Liver Disease (MELD) as a criterion for organ allocation was effective, we studied risk factors for patient deaths and the accuracy of the MELD score to predict mortality.
METHODS: Patients on the waiting list for liver transplantation were divided into two periods depending on whether they were on the waiting list before (period 1) or after (period 2) the MELD introduction in Brazil. The Kaplan-Meier method with log-rank tests were used to study patient survivals. Predictive factors were identified using the Cox regression method. A receiver operating characteristic (ROC) curve was used to analyze Child-Turcotte-Pugh (CTP) and MELD accuracy.
RESULTS: We analyzed 295 patients in period 1 and 240 in period 2. The survivals after 3, 6, 9, and 12 months in periods 1 and 2, were 95.6%, 90.5%, 84.9%, and 69.6% vs 95.7%, 92.1%, 85.3%, and 83.3%, respectively (P = NS). Multivariate analysis showed CTP, MELD-Na, and albumin levels, besides spontaneous bacterial peritonitis (SBP), to be independent factors related to survival in period 1. In period 2, CTP, creatinine levels, international normalized ratio, besides spontaneous bacterial peritonitis, were the independent factors. The ROC curve for CTP was 0.676 and for MELD, 0.644 (P = .4) in period 1. In period 2, the ROC curve for CTP was 0.680 and for MELD, 0.718 (P = .4).
CONCLUSION: Patient survival on the waiting list for liver transplantation did not change at 1 year after the introduction of the MELD. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304153     DOI: 10.1016/j.transproceed.2010.01.028

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  An experience of liver transplantation in Latin America: a medical center in Colombia.

Authors:  Oscar Santos; Mauricio Londoño; Juan Marín; Octavio Muñoz; Álvaro Mena; Carlos Guzmán; Sergio Hoyos; Juan Restrepo; María Arbeláez; Gonzalo Correa
Journal:  Colomb Med (Cali)       Date:  2015-03-30

2.  Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center.

Authors:  Hea-Seon Ha; Jung-Ja Hong; In-Ok Kim; Sae-Rom Lee; Ah-Young Lee; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Sung-Gyu Lee; Shin Hwang
Journal:  Korean J Transplant       Date:  2019-12-31

3.  Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil.

Authors:  Thales Paulo Batista; Bernardo David Sabat; Paulo Sérgio V Melo; Luiz Eduardo C Miranda; Olival Cirilo L Fonseca-Neto; Américo Gusmão Amorim; Cláudio Moura Lacerda
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation center.

Authors:  Soo-Min Ha; Shin Hwang; Gi-Won Song; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Dong-Hwan Jung; Gil-Chun Park; Ki-Hun Kim; Dae-Yeon Kim; Jungman Namgung; Woo-Hyoung Kang; Seok-Hwan Kim; Eunkyoung Jwa; Jae-Hyeon Kwon; Hui-Dong Cho; Yong-Kyu Jung; Sang-Hyeon Kang; Sung-Gyu Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.